LQDA•A district court found claims 1 and 14 of the ‘327 patent valid and infringed by Liquidia, while finding the remaining asserted claims invalid. UTHR requested injunctive relief to restrict Yutrepia’s market availability.
The district court ruled that claims 1 and 14 of the ‘327 patent are valid and infringed by Liquidia, while the remaining asserted claims against the company were found invalid. The parties will submit a proposed judgment specifying a remedy within one week. UTHR requested injunctive relief to restrict Yutrepia’s market availability, and Liquidia said it respectfully disagrees with the court’s decision regarding claims 1 and 14.
